A5HYX0 AF NFT

ATP-dependent helicase/deoxyribonuclease subunit B

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiglqsgn6ed3shhgwzkeulqh3pfqffqirwj3t32e5opxqqwxxayy24/metadata.json
IPFS of structure file: 
bafybeifsgj6e27fqxzwf57fh6iutuhj2kau5b6rtzfwtrgrpmf57ggnfyu/AF-A5HYX0-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x9E875E98F8112e68418e5aC87B39A21D41a95A53
First NFT owner address (bech32): 
genesis1n6r4ax8czyhxssvwtty8kwdzr4q6jkjn9khec4
Current NFT ID #9593 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
9593
Accession (UniProt):
A5HYX0
Name::
ATP-dependent helicase/deoxyribonuclease subunit B
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A5HYX0 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A5HYX0|ADDB_CLOBH ATP-dependent helicase/deoxyribonuclease subunit B OS=Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A) OX=441771 GN=addB PE=3 SV=1 MSLRFIYGRAGSGKSQYCLNSIKNRIEEDIDRPLILLVPEQFSFQAEKNLIEVLDEKTGFKTQVLSFKRMAYRVFNEVGGITAKHMNESGKSMLLYNIIEDNKNNLKVFKKAAKRQGFITTISDIITEFKRYNITPEIILNNLENIEGDNLKYKMEDLALIFSQFETRLHKNYIDNEDDLTILAEKLNKSKQFDNAEIWIDEFSSFSPQEYSVLEKLLLKSYRINITLCTDYLNQGRFVDTTDVFSPIKNTENKLLQIIEDNNIKLDKPIALNCDPCARFKNSAELQHLEKNMFSFPYKEYKNETKDICMLKTLNQFTEIENTAKDIIKLCIDKGCRFKDIAVITGDLEGYENIISSVFLQYNIPFFIDKKREINNNPIIVLILSALEVLSKNWTYESVFRYLKTGLLDINNEEMDILENYVLANGIKGYQWTNDKPWEHKFFSNYELEDQVEKELLAKINDIRYKAMEPIVTLNKNFKSIDKAKEFCEVLYEFLCNINLPDKIQNMIEDFKVEGEIEKASEYNQIWNIVMEVLDQIVEVIGEEKISLKEFFKILQTGLSEYEIGLIPPTLDQVMVGSITRLRSHNINTLYIVGVNDGIFPSPLKEEGILSDDDRKFLGDKGLEIAKDTKSIAFEEQFLVYSTLTTPSKYLRLSYPIADGEGKTLRPSIIISRIKKIFTNICEENDIVKLNGEEEELKNISSAKPTFNYLISNLRKDVEGAKIDNIWGDTYKWYLENEFWIEKLNRLIKGFDYTNQSKYIETKKIRNLYGKPLKISVSRVEKFSQCPFAYFVQYGLKAKDRKIFNLSYPDLGIFMHSILEKFSHELEKQGLEWDTMDLNWAEEEIDKLINEELDNKSLDILNSSKRYEYVTKSVKKILKRSIWLIGEHIKRGNFKPSYYELSFDIDGDYPPIAMELHSGEVVNLIGRVDRVDLLQKDGATYLKIIDYKSGAKEFKLSDVYYGLQLQLLIYLDAILTELAERSGINGEPGALLYLKLDDPIVKNTVDMSDEEIEKSIIKNLKMKGLILNDPNVIRDMDNIISGISDIIPVMVKKDGGVSEGRSSVATKEEFETLRKYVRYTIIEICEEMLEGNIEIKPYKKKDGSSCDYCIYSSVCKFDTNIRGNKYNILIDKKDEEVWDAIKKKLEYKNI